Evidence map›Paper›PMID 36671324›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Development of a Predictive Dosing Nomogram to Achieve PK/PD Targets of Amikacin Initial Dose in Critically Ill Patients: A Non-Parametric Approach.

Anne Coste, Ronan Bellouard, Guillaume Deslandes, Laurence Jalin, Claire Roger, Séverine Ansart, Eric Dailly, Cédric Bretonnière, Matthieu Grégoire

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Anne CosteService de Maladies Infectieuses et Tropicales, CHU de Brest, 29200 Brest, France.ORCID 0000-0002-9596-662X
Ronan BellouardCibles et Médicaments des Infections et de l'Immunité, 9 IICiMed, UR1155, Nantes Université, 44000 Nantes, France.ORCID 0000-0002-2550-9255
Guillaume DeslandesService de Pharmacologie Clinique, CHU Nantes, 44000 Nantes, France.
Laurence JalinUnité de Neuro-Anesthésie-Réanimation, Groupe Hospitalier Pitié-Salpétrière, AP-HP, 75013 Paris, France.
Claire RogerDépartement d'anesthésie et réanimation, douleur et médecine d'urgence, CHU Carémeau, 30029 Nîmes, France.ORCID 0000-0002-6055-0034
Séverine AnsartService de Maladies Infectieuses et Tropicales, CHU de Brest, 29200 Brest, France.
Eric DaillyCibles et Médicaments des Infections et de l'Immunité, 9 IICiMed, UR1155, Nantes Université, 44000 Nantes, France.ORCID 0000-0002-5400-335X
Cédric BretonnièreService des Soins Intensifs de Pneumologie, CHU Nantes, 44000 Nantes, France.ORCID 0000-0002-4942-3253
Matthieu GrégoireCibles et Médicaments des Infections et de l'Immunité, 9 IICiMed, UR1155, Nantes Université, 44000 Nantes, France.
Centre Hospitalier Universitaire de Nantes · FRInserm · FRAssistance Publique – Hôpitaux de Paris · FRUniversité de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

French guidelines recommend reaching an amikacin concentration of ≥8 × MIC 1 h after beginning infusion (C

Indexed as

amikacindosingICUnomogramspharmacokinetics

Identifiers

PMID36671324
PMCPMC9854650
OpenAlexW4313827828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.